Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - teriparatide - solution for injection - 250microgram/1ml

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - teriparatide - solution for injection - 250microgram/1ml

Japan - engelsk - すりの適正使用協議会 RAD-AR Council, Japan

asahi kasei pharma corporation - teriparatide acetate - injection

Den europeiske union - italiensk - EMA (European Medicines Agency)

stada arzneimittel ag - teriparatide - osteoporosi - omeostasi del calcio - movymia è indicato negli adulti. trattamento dell'osteoporosi nelle donne in postmenopausa e negli uomini a maggior rischio di frattura. nelle donne in postmenopausa è stata dimostrata una significativa riduzione dell'incidenza di fratture vertebrali e non vertebrali ma non di fratture dell'anca. trattamento dell'osteoporosi associata sostenuto sistemica terapia con glucocorticoidi nelle donne e negli uomini ad aumentato rischio di frattura.

Den europeiske union - italiensk - EMA (European Medicines Agency)

gedeon richter plc. - teriparatide - osteoporosi - omeostasi del calcio - terrosa è indicato negli adulti. trattamento dell'osteoporosi nelle donne in postmenopausa e negli uomini a maggior rischio di frattura. nelle donne in postmenopausa è stata dimostrata una significativa riduzione dell'incidenza di fratture vertebrali e non vertebrali ma non di fratture dell'anca. trattamento dell'osteoporosi associata sostenuto sistemica terapia con glucocorticoidi nelle donne e negli uomini ad aumentato rischio di frattura.

Den europeiske union - italiensk - EMA (European Medicines Agency)

strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - omeostasi del calcio - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Den europeiske union - italiensk - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriparatide - osteoporosi - omeostasi del calcio - sondelbay is indicated in adults. trattamento dell'osteoporosi nelle donne in postmenopausa e negli uomini a maggior rischio di frattura. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. trattamento dell'osteoporosi associata sostenuto sistemica terapia con glucocorticoidi nelle donne e negli uomini ad aumentato rischio di frattura.

Den europeiske union - nederlandsk - EMA (European Medicines Agency)

strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - calcium homeostase - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Den europeiske union - nederlandsk - EMA (European Medicines Agency)

stada arzneimittel ag - teriparatide - osteoporose - calcium homeostase - movymia is geïndiceerd voor volwassenen. behandeling van osteoporose bij postmenopauzale vrouwen en bij mannen met een verhoogd risico op fracturen. bij postmenopauzale vrouwen is een significante vermindering van de incidentie van wervel- en niet-wervelbreuken maar niet van heupfracturen aangetoond. de behandeling van osteoporose in verband met de aanhoudende systemische glucocorticoïden therapie bij vrouwen en mannen met een verhoogd risico op fracturen.

Den europeiske union - nederlandsk - EMA (European Medicines Agency)

gedeon richter plc. - teriparatide - osteoporose - calcium homeostase - terrosa is geïndiceerd voor gebruik bij volwassenen. behandeling van osteoporose bij postmenopauzale vrouwen en bij mannen met een verhoogd risico op fracturen. bij postmenopauzale vrouwen is een significante vermindering van de incidentie van wervel- en niet-wervelbreuken maar niet van heupfracturen aangetoond. de behandeling van osteoporose in verband met de aanhoudende systemische glucocorticoïden therapie bij vrouwen en mannen met een verhoogd risico op fracturen.